Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review-Reference-Cited by-同舟云学术

Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review

Published:2017-01-10 Issue:9 Volume:35 Page:1401-1407
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Aziz Atiqullah, ,Dobruch Jakub,Hendricksen Kees,Kluth Luis A.,Necchi Andrea,Noon Aidan,Rink Michael,Roghmann Florian,Seiler Roland,Gontero Paolo,Kassouf Wassim,Shariat Shahrokh F.,Xylinas Evanguelos

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/article/10.1007/s00345-016-1995-z/fulltext.html

Reference39 articles.

1. Roupret M, Babjuk M, Comperat E et al (2013) European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 63:1059–1071

2. Margulis V, Shariat SF, Matin SF et al (2009) Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115:1224–1233

3. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K (2007) Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology 69:265–269

4. Advanced Bladder Cancer Meta-analysis C (2005) Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 48:202–205 (discussion 05-6)

5. Leow JJ, Martin-Doyle W, Rajagopal PS et al (2014) Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials. Eur Urol 66:42–54

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant Chemotherapy in Patients with Locally Advanced Upper Tract Urothelial Carcinoma with or without Kidney Transplantation;Journal of Clinical Medicine;2024-03-22

2. Survival and risk factors among upper tract urothelial carcinoma patients after radical nephroureterectomy in Northeast China;Frontiers in Oncology;2022-10-25

3. First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer;International Journal of Clinical Oncology;2022-08-27

4. Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy;European Urology Open Science;2022-07

5. Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma;Urologic Oncology: Seminars and Original Investigations;2021-11